Physician Assistant Exam Review

  • About
  • Contact
  • Blueprint
  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails
You are here: Home / Cardiology / S2 E027 Atherosclerosis and Dyslipidemia: A review for the PANC

S2 E027 Atherosclerosis and Dyslipidemia: A review for the PANC

http://traffic.libsyn.com/physicianassistantexamreview/S2_027.mp3

Podcast: Play in new window | Download

<< Click here to get 22 Cardiology questions straight from my book, The Final Step >>

Atherosclerosis

Components of atherosclerosis

  • Lipid deposition
  • Fibrosis
  • Calcifications
  • Plaque in the intima of medium and large blood vessels
  • Atherosclerosis is the number one cause of cardiac-related death and disability.

Risk Factors

  • HTN
  • Dyslipidemia
  • Smoking
  • Diabetes
  • Advancing age
  • Family history
  • Males to Female = 4:1

Clinical Presentation

  • No symptoms at all
  • Symptoms of ischemia by location
    • Cerebral – cognitive dysfunction
    • Renal – kidney failure
    • Cardiac – Chest pain, MI
    • Intestinal – abdominal pain

Physical Exam findings

A bruit may be present over an artery which is partially occluded.

Labs & Studies

  • U/S doppler – blood flow
  • Ankle brachial index
    • This compares BP in the upper versus lower extremities. This can be used to determine patency of the arteries for patients with peripheral vascular disease.
  • Angiogram
    • Visualize the arteries under x-ray. This is a patient who uploaded his video of his own cardiac cath.

Treatment

  • Decrease risk factors
    • Control HTN
    • Better control of lipids
      • A reduction of total cholesterol even in those with diagnosed CAD correlates with reduction in total mortality
    • Quit smoking!!
    • Diabetes control
  • Medical treatment
    • Blood thinner
      • Aspirin 81 mg or 325 mg daily
    • Treat dyslipidemia
  • Surgery
    • Endarterectomy
    • Stents and balloons

Dyslipidemia

  • Low-density lipoprotein (LDL) (lousy)
    • Increased LDL correlates with an increased risk of heart disease.
  • High-density lipoprotein (HDL) (happy)
    • Increased HDL correlates with a decreased risk of heart disease.
  • Triglycerides
    • An increase in triglycerides is correlated to a an increased risk of heart disease.

Causes and correlations

  • Straight out of the Merck Manual “The most important secondary cause in developed countries is a sedentary lifestyle with excessive dietary intake of saturated fat, cholesterol, and trans fats”
  • Genetics
  • Diabetes
  • Liver or kidney disease
  • Hypothyroidism
  • Alcoholism
  • Medications

Clinical presentation

  • Asymptomatic
  • Routine office visit
    • Routine screening should begin at 35 for men and 45 for women
  • Signs of CAD

Physical Exam findings

  • Xanthomas are possible, but more than half of people with them have an normal lipid profile.

Labs and Studies

  • Serum Lipid Profile (fasting)
  • Total Cholesterol
    • Optimal < 200
    • Borderline high 200–239
    • High >240
  • HDL
    • Low < 40
    • High > 60
  • LDL
    • Optimal < 100
    • Near Optimal 100–129
    • Borderline high 130–159
    • High 160–189
    • Very high >190
  • Triglycerides
    • Normal < 150
    • Borderline high 150–199
    • High 200–499
    • Very high >500

Treatment

  • Non-pharmacological
    • Diet
      • Reduce dietary fat to 30% and saturated fat to < 10%
      • Mediterranean diet
    • Increase in aerobic exercise helps to increase HDL levels
    • Weight reduction
  • Medications
    • 81 mg or 325 mg of Aspirin Daily for those with elevated LDL
    • Statins
      • 3-Hydroxy–3-methylglutaryl coenzyme A reductase inhibitors (HMG-CoA inhibitors)
      • Inhibit rate limiting step in cholesterol production
      • Examples
        • Lovastatin, Pravastatin, Simvastatin, Atorvastatin
      • Most common side effect – Myositis
  • Postmenopausal estrogen replacement helps lower LDL and raise HDL
  • Niacin is effective but may cause flushing in patients and is not well tolerated
  • Bile acid binding resins
    • Cholestyramine, Colestipol,
  • Fibric acid derivatives
    • Gemfibrozil, Fenofibrate

 

<< Click here to get 22 Cardiology questions straight from my book, The Final Step >>

  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails

logo Privacy Policy | Fulfillment Policy | Terms of Service | Web design by OptimWise

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}